Kolon TissueGene Hopes To Regain Credibility As Stock Trading Resumes

Shares Surge By Daily High

Following its decision to maintain a stock listing for SillaJen earlier this month, the Korea Exchange has done the same for Kolon TissueGene, which had faced delisting but has resumed trading amid decisive moves to improve its business.

Kolon TissueGene Researchers
Korea Exchange Decides To Maintain Kolon TissueGene Listing • Source: Kolon TissueGene Inc.

More from South Korea

More from Focus On Asia